Logo image of CROS.PA

CROSSWOOD (CROS.PA) Stock Fundamental Analysis

Europe - EPA:CROS - FR0000050395 - Common Stock

10.9 EUR
0 (0%)
Last: 10/16/2025, 7:00:00 PM
Fundamental Rating

4

Overall CROS gets a fundamental rating of 4 out of 10. We evaluated CROS against 72 industry peers in the Real Estate Management & Development industry. While CROS has a great health rating, its profitability is only average at the moment. CROS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

CROS had positive earnings in the past year.
CROS had a negative operating cash flow in the past year.
CROS had positive earnings in 4 of the past 5 years.
CROS had a positive operating cash flow in 4 of the past 5 years.
CROS.PA Yearly Net Income VS EBIT VS OCF VS FCFCROS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M

1.2 Ratios

CROS has a Return On Assets of 4.51%. This is amongst the best in the industry. CROS outperforms 87.50% of its industry peers.
With a decent Return On Equity value of 5.39%, CROS is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
ROA 4.51%
ROE 5.39%
ROIC N/A
ROA(3y)3.13%
ROA(5y)5.13%
ROE(3y)3.87%
ROE(5y)6.65%
ROIC(3y)N/A
ROIC(5y)N/A
CROS.PA Yearly ROA, ROE, ROICCROS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8 10

1.3 Margins

CROS has a Profit Margin of 1179.90%. This is amongst the best in the industry. CROS outperforms 100.00% of its industry peers.
In the last couple of years the Profit Margin of CROS has grown nicely.
CROS's Operating Margin has declined in the last couple of years.
CROS has a Gross Margin (50.00%) which is comparable to the rest of the industry.
CROS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 1179.9%
GM 50%
OM growth 3Y-15.69%
OM growth 5Y-19.63%
PM growth 3Y0.74%
PM growth 5Y7.35%
GM growth 3Y-2.67%
GM growth 5Y-2.18%
CROS.PA Yearly Profit, Operating, Gross MarginsCROS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600

More info and screens

9

2. Health

2.1 Basic Checks

CROS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CROS has about the same amount of shares outstanding.
Compared to 5 years ago, CROS has about the same amount of shares outstanding.
Compared to 1 year ago, CROS has an improved debt to assets ratio.
CROS.PA Yearly Shares OutstandingCROS.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CROS.PA Yearly Total Debt VS Total AssetsCROS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

CROS has an Altman-Z score of 5.29. This indicates that CROS is financially healthy and has little risk of bankruptcy at the moment.
CROS's Altman-Z score of 5.29 is amongst the best of the industry. CROS outperforms 94.44% of its industry peers.
CROS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.29
ROIC/WACCN/A
WACC8.06%
CROS.PA Yearly LT Debt VS Equity VS FCFCROS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

CROS has a Current Ratio of 8.88. This indicates that CROS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 8.88, CROS belongs to the top of the industry, outperforming 94.44% of the companies in the same industry.
A Quick Ratio of 8.88 indicates that CROS has no problem at all paying its short term obligations.
CROS's Quick ratio of 8.88 is amongst the best of the industry. CROS outperforms 95.83% of its industry peers.
Industry RankSector Rank
Current Ratio 8.88
Quick Ratio 8.88
CROS.PA Yearly Current Assets VS Current LiabilitesCROS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

CROS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 201.96%, which is quite impressive.
The Earnings Per Share has been decreasing by -3.78% on average over the past years.
The Revenue for CROS has decreased by -61.47% in the past year. This is quite bad
CROS shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -10.37% yearly.
EPS 1Y (TTM)201.96%
EPS 3Y-11.3%
EPS 5Y-3.78%
EPS Q2Q%-40.84%
Revenue 1Y (TTM)-61.47%
Revenue growth 3Y-11.95%
Revenue growth 5Y-10.37%
Sales Q2Q%-89.13%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CROS.PA Yearly Revenue VS EstimatesCROS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CROS is valuated quite expensively with a Price/Earnings ratio of 25.35.
CROS's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of CROS to the average of the S&P500 Index (27.57), we can say CROS is valued inline with the index average.
Industry RankSector Rank
PE 25.35
Fwd PE N/A
CROS.PA Price Earnings VS Forward Price EarningsCROS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CROS.PA Per share dataCROS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

CROS has a Yearly Dividend Yield of 2.14%.
CROS's Dividend Yield is comparable with the industry average which is at 7.52.
CROS's Dividend Yield is comparable with the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 2.14%

5.2 History

The dividend of CROS is nicely growing with an annual growth rate of 156.54%!
Dividend Growth(5Y)156.54%
Div Incr Years0
Div Non Decr Years0
CROS.PA Yearly Dividends per shareCROS.PA Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 0.1 0.2 0.3

5.3 Sustainability

23.22% of the earnings are spent on dividend by CROS. This is a low number and sustainable payout ratio.
DP23.22%
EPS Next 2YN/A
EPS Next 3YN/A
CROS.PA Yearly Income VS Free CF VS DividendCROS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M
CROS.PA Dividend Payout.CROS.PA Dividend Payout, showing the Payout Ratio.CROS.PA Dividend Payout.PayoutRetained Earnings

More info and screens

CROSSWOOD

EPA:CROS (10/16/2025, 7:00:00 PM)

10.9

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners63.48%
Inst Owner ChangeN/A
Ins Owners95.04%
Ins Owner ChangeN/A
Market Cap115.87M
Revenue(TTM)388.00K
Net Income(TTM)4.58M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.14%
Yearly Dividend0.1
Dividend Growth(5Y)156.54%
DP23.22%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 25.35
Fwd PE N/A
P/S 298.63
P/FCF N/A
P/OCF N/A
P/B 1.36
P/tB 1.36
EV/EBITDA N/A
EPS(TTM)0.43
EY3.94%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS0.04
BVpS7.99
TBVpS7.99
PEG (NY)N/A
PEG (5Y)N/A
Graham Number8.79
Profitability
Industry RankSector Rank
ROA 4.51%
ROE 5.39%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1179.9%
GM 50%
FCFM N/A
ROA(3y)3.13%
ROA(5y)5.13%
ROE(3y)3.87%
ROE(5y)6.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)0.52%
ROCE(5y)0.67%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-15.69%
OM growth 5Y-19.63%
PM growth 3Y0.74%
PM growth 5Y7.35%
GM growth 3Y-2.67%
GM growth 5Y-2.18%
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.88
Quick Ratio 8.88
Altman-Z 5.29
F-Score4
WACC8.06%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)39.93%
Cap/Sales(5y)36.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)201.96%
EPS 3Y-11.3%
EPS 5Y-3.78%
EPS Q2Q%-40.84%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-61.47%
Revenue growth 3Y-11.95%
Revenue growth 5Y-10.37%
Sales Q2Q%-89.13%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-134.26%
EBIT growth 3Y-25.77%
EBIT growth 5Y-27.97%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-864.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-699.12%
OCF growth 3Y52.86%
OCF growth 5YN/A